Visit
A three-part session with experts Solange Peters, Martin Reck, and Sanjay Popat, who discuss the latest updates in lung cancer…
Advances in treatment options for anaplastic lymphoma kinase (ALK+) non-small cell lung cancer (NSCLC) have improved patient outcomes considerably in…
The first interim results of the Phase III ADAURA study evaluating adjuvant osimertinib in stage IB-IIIA EGFR-mutated non-small cell lung…
The early detection of cancer improves outcomes for patients – in terms of both reducing treatment burden and improving the…
Clinical trials assessing the efficacy of pembrolizumab have previously enrolled patients with performance status (PS) 0–1. However, almost a fifth…
The early detection of lung cancer is an exciting field with the potential to greatly improve patient survival. The topic…
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest oncology news and updates
Keep up to date with all the latest news with our monthly newsletter